US Stock MarketDetailed Quotes

WCGC WCG Clinical

Watchlist
  • 0.000
  • 0.0000.00%
Close Nov 29 09:30 ET
0Market Cap0.00P/E (TTM)

WCG Clinical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q1)Mar 31, 2020
(FY)Dec 31, 2019
Total revenue
32.99%137.64M
12.26%463.44M
103.5M
412.85M
Operating revenue
32.99%137.64M
12.26%463.44M
--103.5M
--412.85M
Cost of revenue
38.37%51.56M
7.26%169.13M
37.26M
157.69M
Gross profit
29.96%86.08M
15.34%294.31M
66.24M
255.16M
Operating expense
13.13%81.65M
90.80%295.73M
72.17M
155M
Selling and administrative expenses
34.63%28.6M
-0.40%90.04M
--21.25M
--90.4M
Depreciation amortization depletion
4.16%53.04M
218.41%205.7M
--50.92M
--64.6M
-Depreciation and amortization
4.16%53.04M
218.41%205.7M
--50.92M
--64.6M
Operating profit
174.74%4.44M
-101.42%-1.42M
-5.93M
100.16M
Net non-operating interest income expense
4.65%-21.74M
-64.77%-91.31M
-22.79M
-55.42M
Non-operating interest expense
-4.65%21.74M
64.77%91.31M
--22.79M
--55.42M
Other net income (expense)
47.94%-9.09M
-54.46%-41.45M
-17.46M
-26.83M
Special income (charges)
48.11%-9.06M
-43.60%-38.47M
---17.46M
---26.79M
-Less:Restructuring and merger&acquisition
-48.11%9.06M
43.60%38.47M
--17.46M
--26.79M
Other non- operating income (expenses)
-412.50%-25K
-6,820.93%-2.98M
--8K
---43K
Income before tax
42.86%-26.39M
-849.01%-134.18M
-46.18M
17.91M
Income tax
64.18%-5.76M
-13,844.09%-38.9M
-16.09M
-279K
Net income
31.46%-20.62M
-623.68%-95.27M
-30.09M
18.19M
Net income continuous Operations
31.46%-20.62M
-623.68%-95.27M
---30.09M
--18.19M
Minority interest income
Net income attributable to the parent company
31.46%-20.62M
-623.68%-95.27M
-30.09M
18.19M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
31.46%-20.62M
-623.68%-95.27M
-30.09M
18.19M
Basic earnings per share
31.95%-0.054
-623.15%-0.251
-0.0794
0.048
Diluted earnings per share
31.95%-0.054
-623.15%-0.251
-0.0794
0.048
Dividend per share
Currency Unit
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q1)Mar 31, 2020(FY)Dec 31, 2019
Total revenue 32.99%137.64M12.26%463.44M103.5M412.85M
Operating revenue 32.99%137.64M12.26%463.44M--103.5M--412.85M
Cost of revenue 38.37%51.56M7.26%169.13M37.26M157.69M
Gross profit 29.96%86.08M15.34%294.31M66.24M255.16M
Operating expense 13.13%81.65M90.80%295.73M72.17M155M
Selling and administrative expenses 34.63%28.6M-0.40%90.04M--21.25M--90.4M
Depreciation amortization depletion 4.16%53.04M218.41%205.7M--50.92M--64.6M
-Depreciation and amortization 4.16%53.04M218.41%205.7M--50.92M--64.6M
Operating profit 174.74%4.44M-101.42%-1.42M-5.93M100.16M
Net non-operating interest income expense 4.65%-21.74M-64.77%-91.31M-22.79M-55.42M
Non-operating interest expense -4.65%21.74M64.77%91.31M--22.79M--55.42M
Other net income (expense) 47.94%-9.09M-54.46%-41.45M-17.46M-26.83M
Special income (charges) 48.11%-9.06M-43.60%-38.47M---17.46M---26.79M
-Less:Restructuring and merger&acquisition -48.11%9.06M43.60%38.47M--17.46M--26.79M
Other non- operating income (expenses) -412.50%-25K-6,820.93%-2.98M--8K---43K
Income before tax 42.86%-26.39M-849.01%-134.18M-46.18M17.91M
Income tax 64.18%-5.76M-13,844.09%-38.9M-16.09M-279K
Net income 31.46%-20.62M-623.68%-95.27M-30.09M18.19M
Net income continuous Operations 31.46%-20.62M-623.68%-95.27M---30.09M--18.19M
Minority interest income
Net income attributable to the parent company 31.46%-20.62M-623.68%-95.27M-30.09M18.19M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 31.46%-20.62M-623.68%-95.27M-30.09M18.19M
Basic earnings per share 31.95%-0.054-623.15%-0.251-0.07940.048
Diluted earnings per share 31.95%-0.054-623.15%-0.251-0.07940.048
Dividend per share
Currency Unit USDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data